Transmucosal Drug Delivery Devices – Medical Devices Pipeline Assessment, 2019

Research By Markets adds Market Research Report - Transmucosal Drug Delivery Devices – Medical Devices Pipeline Assessment, 2019

For detailed information: https://www.researchbymarkets.com/report/transmucosal-drug-delivery-devices-medical-devices-pipeline-assessment-2019-342545.html

Transmucosal Drug Delivery Devices – Medical Devices Pipeline Assessment, 2019

Summary

Medical Devices sector report, “Transmucosal Drug Delivery Devices – Medical Devices Pipeline Assessment, 2019” provides an overview of Transmucosal Drug Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transmucosal Drug Delivery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Transmucosal Drug Delivery Devices under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Transmucosal Drug Delivery Devices and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry.

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Transmucosal Drug Delivery Devices under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date.

Companies Mentioned:
AcelRx Pharmaceuticals Inc
Aegis Therapeutics LLC
AFYX Therapeutics A/S
Albert Einstein College of Medicine
Allergan Plc
Amphastar Pharmaceuticals Inc
Aquestive Therapeutics Inc
ARS Pharmaceuticals Inc
Auritec Pharmaceuticals Inc
BeFree!
Bespak Europe Ltd
Biorings LLC
BioXcel Therapeutics Inc
Callitas Therapeutics Inc
Columbia University
Combinent BioMedical Systems Inc
Conrad
Dare Bioscience Inc
Emergent BioSolutions Inc
Evestra Inc
Evofem Biosciences Inc
Evoke Pharma Inc
EyeGate Pharmaceuticals Inc
Ferring Pharmaceuticals AS
Ghent University
Glenmark Pharmaceuticals Ltd
Hebrew University of Jerusalem
INSYS Therapeutics Inc
IntelGenx Corp
Janssen Research & Development LLC
Karessa Pharma AB
Kytogenics Pharmaceuticals Inc
Laboratoire HRA Pharma SAS
Laboratorios Andromaco
Lyra Therapeutics
McNeil AB
Medlab Clinical Ltd
Merck & Co Inc
Merck Serono SA
Merck Sharp & Dohme Ltd
Mithra Pharmaceuticals SA
Mystic Pharmaceuticals Inc
Nanosys Inc
NorInvent AB
Novus Therapeutics Inc
Oak Crest Institute of Science
Opiant Pharmaceuticals Inc
OptiNose AS
Orion Biotechnology Canada Ltd
Orphanse Healthcare SAS
Palette Life Sciences AB
Phoenix Life Sciences International Ltd
Privo Technologies LLC
Promius Pharma LLC
RDD Pharma Ltd
Renown Pharma Ltd
Rhinomed Ltd
Scientus Pharma Inc
Shenox Pharmaceuticals LLC
Shin Nippon Biomedical Laboratories Ltd
Suda Pharmaceuticals Ltd
Texas Tech University
The Hong Kong University of Science and Technology
Therakind Ltd
TherapeuticsMD Inc
Tiziana Life Sciences PLC
UCB SA
University of North Carolina at Chapel Hill
University of Pittsburgh
University of South Florida
University of Texas at Austin
University of the Witwatersrand
University of Washington
Washington University in St Louis


For queries regarding this report: https://www.researchbymarkets.com/sample-request/342545

Contact Us:
ResearchByMarkets.com
Sales Desk
enquiry@researchbymarkets.com
USA: +1-800-416-3124
https://www.researchbymarkets.com
https://www.researchbymarkets.com/aboutus

Follow us on Social Media:
Facebook: https://www.facebook.com/researchbymarkets/
LinkedIn: https://www.linkedin.com/company/researchmarkets
Twitter: https://twitter.com/ResearchByMrkts

Ritesh Tiwari is the Founder of Research By Markets, a leading Market Research Reports Reseller trusted by Fortune listed companies for their requirements of Syndicated and Custom Market Research Reports. Ritesh has an overall experience of 18+ years in Recruitments, Sales and Operations. He has been associated with the Market Research industry for the past 7 years. He is an avid foodie as well as a huge football fan being a supporter of Manchester United (EPL) and FC Barcelona (La Liga). Get in touch with him via ritesh@researchbymarkets.com. *Market Research News is a part of Research By Markets.